Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|November 19, 2015
Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylationAnna Maria Mileo, Stefano Mattarocci, Paola Matarrese, et al.
Biotechnology Journal|December 24, 2017
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral AntigensSimona Anticoli, Francesco Manfredi, Chiara Chiozzini, et al.
International Journal of Environmental Research and Public Health|January 8, 2020
Sex Disparity in Response to Hepatitis B Vaccine Related to the Age of VaccinationAndrea Trevisan, Alessandro Giuliani, Maria Luisa Scapellato, et al.
International Journal of Nanomedicine|July 12, 2017
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculationPaola Di Bonito, Chiara Chiozzini, Claudia Arenaccio, et al.
Pharmacological Research|August 28, 2021
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equityAndrea Spini, Valentina Giudice, Vincenzo Brancaleone, et al.
Vaccines|August 29, 2024
B Cells Isolated from Individuals Who Do Not Respond to the HBV Vaccine Are Characterized by Higher DNA Methylation-Estimated Aging Compared to RespondersKatarzyna Malgorzata Kwiatkowska, Simona Anticoli, Stefano Salvioli, et al.
Frontiers in Immunology|April 27, 2026
B-cell DNA methylation signature in response to hepatitis B virus vaccination in females and malesKatarzyna Malgorzata Kwiatkowska, Simona Anticoli, Stefano Salvioli, et al.
Vaccines|January 8, 2025
Epigenetic Drift Is Involved in the Efficacy of HBV VaccinationFrancesca Ferraresi, Simona Anticoli, Stefano Salvioli, et al.
Current HIV Research|August 12, 2008
Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1Sandro Norelli, Sary El Daker, Daniela D'Ostilio, et al.
Frontiers in Immunology|September 4, 2018
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid ArthritisMaria Luisa Dupuis, Fabrizio Conti, Angela Maselli, et al.
Pageof 4